The FUTURE of ErbB-1 and ErbB-2 pathway inhibition in breast cancer: targeting multiple receptors.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/D424EBDC.svg?ark=w1%2F20260515%2FD424EBDC)](https://nobleid.org/work/w1/20260515/D424EBDC)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors